FreezeM offers a technology designed to improve the use of insects as a protein source for animal feed.

ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company focused on developing a pipeline of disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways.

Alma Bio Therapeutics is a biotechnology company pioneering a new class of therapeutic that reinforces the natural built-in mechanism for disease resolution and healing and restores the ability of

NanoCell Ltd.

DayTwo is a microbiome-based precision medicine company developing personalized nutrition, diagnostic, and therapeutic solutions using artificial intelligence and machine learning.

BiomX is a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and colorectalcancer

SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology.

Photomyne is an application that enables users to digitally capture entire photo albums in minutes. The company's technology allows users to scan multiple photos at once.

Neurogenic researches and develops diagnostics and therapeutics for mental disorders.

NanoMaterials produces commercially viable inorganic, multilayered nanofullerenes and nanotubes based on patented platform technology developed at the Weizmann Institute of Science.

miCure Therapeutics is a biotechnology company leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric disorders.

Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

IDEA Bio-Medical is a commercial-stage company specializing in solutions for biological cell-imaging research, drug-discovery automation, and diagnostics.

NewCO2Fuels commercializes a technology that uses high-temperature CO2 dissociation to convert CO2 into a variety of fuels.

LifeMap Sciences develops and commercializes next-generation sequencing (NGS) analysis solutions.

NDS Group Ltd. was established in 1985 and developed smart cards to prevent unauthorized access to computer data and satellite television broadcasts.

Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as amyotrophic lateral sclerosis (ALS) an

BiondVax Pharmaceuticals is a biopharmaceutical company developing a universal flu vaccine designed to provide multi-season and multi-strain protection against all human influenza virus strains, bo

Phytolon provides an ultimate solution to the global food colors issue.

UltraSight, a joint venture of Yeda and NYU, has developed AI-based software that revolutionizes point of care diagnosis using ultrasound imaging, by eliminating the

Curesponse is a clinical-stage cancer diagnostics company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance.

Moodify develops unique active scents designed to help people improve their performance, enhance their wellbeing, and increase their safety.

Liposphere is a biomedical start-up developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important.

FortePhest is a biotechnology start-up developing a technology to combat herbicide‐resistant weeds.

EcoBreed develops solutions to fast-track natural plant breeding.

Metabolic Insights aims to develop novel eco-friendly and sustainable products based on purified molecules from plants.

EcoPhage is focused on discovering and developing environmentally friendly products for disease control in agriculture.

Developing advanced proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients ("API") for the pharmaceutical and food industries using biosynthesis a

After decades of research by the global academic community, Quintrigen is on the road to reignite mutant p53 protein, putting it back to work.

Photomyne is an application that enables users to digitally capture entire photo albums in minutes.